JEFFREY WHITNELL

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ELITE PHARMACEUTICALS INC /NV/

Filing Date Source Excerpt
2009-09-08 Jeffrey Whitnell is recommended by the Board for election as a Board member. Jerry Treppel, the Chairman of the Board, a non-management director and holder of Elite shares (555,000 share of common and 882,113 warrants) nominated Mr. Whitnell. ... Mr. Whitnell previously served as Chief Financial Officer and Senior Vice President of Finance at Akorn, Inc. between June 2004 to June 2009.
2011-08-31 Jeffrey Whitnell has served as a Director since October 23, 2009, Chairman of the Audit Committee since October 23, 2009, member of the nominating committee since October 23, 2009 and designated by the Board as an “audit committee financial expert”. Director compensation table shows stock awards $25,000 and all other compensation $5,000 totaling $30,000.
2014-04-03 Jeffrey Whitnell has served as a Director since October 23, 2009, Chairman of the Audit Committee since October 23, 2009, member of the Nominating Committee since October 23, 2009, member of the Compensation Committee since October 23, 2009. Director compensation table shows total compensation of $20,000.
2019-10-10 Jeffrey Whitnell has served as a Director since October 23, 2009, Chairman of the Audit Committee, member of the Compensation Committee since October 2009 and designated by the Board as an “audit committee financial expert” as defined under applicable rules under the Exchange Act.
2020-04-29 Jeffrey Whitnell, Director*

Data sourced from SEC filings. Last updated: 2026-03-05